Hepatitis B surface antigen (HBsAg) prevalence in Mauritius
Mauritius: Hepatitis B surface antigen (HBsAg) prevalence was 0.8% in 2024. βΌ Falling
Latest (2024)
0.8%
Change on year
unchanged
World rank
39th
of 192 countries
All-time high
1.5%
in 2015
All-time low
0.8%
in 2022
Years of data
10
2015β2024
Hepatitis B surface antigen (HBsAg) prevalence in Mauritius, 2015β2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, hepatitis b surface antigen (hbsag) prevalence in Mauritius stood at 0.8%. That is the lowest value across all 10 years on record.
The figure is down 46.7% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Mauritius peaked at 1.5% in 2015 and was at its lowest, 0.8%, in 2022.
That places Mauritius 39th out of 192 countries with data for 2024, putting it in the top quarter.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.2% | 1.0% | 1.5% | 5 |
| 2020s | 0.8% | 0.8% | 0.9% | 5 |
Countries ranked near Mauritius
- 36 Viet Nam 0.9% compare
- 36 Kiribati 0.9% compare
- 36 Marshall Islands 0.9% compare
- 39 Sao Tome and Principe 0.8% compare
- 39 Seychelles 0.8% compare
- 39 Philippines 0.8% compare
More health data for Mauritius
- Un projection of annual infant deaths, annual growth rate -10 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0345 % change on previous year (2090)
- Heat deaths vs projected death rates 2,032 (2090)
- Un projection of annual infant deaths 9 (2100)
- Population, male, annual growth rate -0.2673 % change on previous year (2025)
- Population, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population, male, per capita 0.4986 units per person (2025)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 25, male, interpolated 9,464 (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Mauritius?
- Hepatitis b surface antigen (hbsag) prevalence in Mauritius was 0.8% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Mauritius?
- The highest recorded value was 1.5% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Mauritius?
- The lowest recorded value was 0.8% in 2022.
- How does Mauritius rank for hepatitis b surface antigen (hbsag) prevalence?
- Mauritius ranks 39th out of 192 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Mauritius?
- Over the last ten years it is down 46.7%. The long-run trend across the full record is falling.
- Where does this Mauritius data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV Β· JSON β 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).